STOCK TITAN

Nutranomics Stock Price, News & Analysis

NNRX OTC

Welcome to our dedicated page for Nutranomics news (Ticker: NNRX), a resource for investors and traders seeking the latest updates and insights on Nutranomics stock.

Our selection of high-quality news articles is accompanied by an expert summary from Rhea-AI, detailing the impact and sentiment surrounding the news at the time of release, providing a deeper understanding of how each news could potentially affect Nutranomics's stock performance. The page also features a concise end-of-day stock performance summary, highlighting the actual market reaction to each news event. The list of tags makes it easy to classify and navigate through different types of news, whether you're interested in earnings reports, stock offerings, stock splits, clinical trials, fda approvals, dividends or buybacks.

Designed with both novice traders and seasoned investors in mind, our page aims to simplify the complex world of stock market news. By combining real-time updates, Rhea-AI's analytical insights, and historical stock performance data, we provide a holistic view of Nutranomics's position in the market.

Rhea-AI Summary

NutraNomics, Inc. (OTC PINK:NNRX) has announced the appointment of Geoffrey Bazegian as President and Chief Revenue Officer, effective immediately. Bazegian, with over 28 years of experience in business development, previously served as SVP of Wholesale Materials. He is tasked with driving NutraNomics' growth through strategic mergers and acquisitions, alongside overseeing global sales. Bazegian has been integral in formulating the company's forward growth plan since joining in 2018, highlighting the firm’s commitment to excellence in plant-based nutritional science.

Rhea-AI Impact
Rhea-AI Sentiment
End-of-Day
33.33%
Tags
none
-
Rhea-AI Summary

NutraNomics, Inc. (OTC: NNRX) announced plans for a strategic acquisition of DHS Development, Inc. dba The Plant, focusing on enhancing its manufacturing and cultivation capabilities. The company intends to invest up to $1M in equipment and facility improvements to meet existing customer demand. This investment aims to support the production of various core cannabis products, including concentrates and edibles, from its 27,000 sq. ft. production facility and an additional 30,000 sq. ft. cultivation space. More acquisition details will follow after the expected closure in mid-February.

Rhea-AI Impact
Rhea-AI Sentiment
End-of-Day
100%
Tags
-
Rhea-AI Summary

NutraNomics (OTC: NNRX) announced a Binding Letter of Intent to acquire assets, IP, and personnel from DHS Development Inc. dba The Plant. This strategic move aims to enhance NutraNomics' growth in the processing and distribution sectors. CEO Jonathan Bishop expressed optimism about the acquisition, highlighting the importance of The Plant’s management in aligning with NutraNomics' mission. Due diligence is underway with a targeted closing anticipated in February.

Rhea-AI Impact
Rhea-AI Sentiment
End-of-Day
33.33%
Tags

FAQ

What is the current stock price of Nutranomics (NNRX)?

The current stock price of Nutranomics (NNRX) is $0.000001 as of May 27, 2025.

What is the market cap of Nutranomics (NNRX)?

The market cap of Nutranomics (NNRX) is approximately 1.6M.
Nutranomics

OTC:NNRX

NNRX Rankings

NNRX Stock Data

1.63M
15.11B
7.43%
Drug Manufacturers - Specialty & Generic
Healthcare
Link
United States
Salt Lake City